ARTICLE | Clinical News
Antineoplaston therapy regulatory update
December 8, 2008 8:00 AM UTC
FDA granted Orphan Drug designation for Burzynski's antineoplaston therapy to treat gliomas. The therapy, which combines injectable Atengenal (antineoplaston A10) and injectable Astugenal (antineoplas...